I recently attend a conference in Florida called The World Stem Cell Summit. It was very enjoyable and unique in that it brings together and is open to all constituents of the stem cell world. I gave a couple talks and did an “expert” luncheon at this meeting, but what I enjoyed most was talking […]
Perfect storm dodged: what are three key challenges for stem cell field going into 2013? Read More »
Here on The Niche I’m giving out a Stem Cell Person of the Year Award for 2012 along with all my other annual awards (e.g. best stem cell journal, paper, blog, comic, activist, etc). 2020 update: you can see future winners of the award here. The Person of the Year winner will get recognition for
Stem Cell Person of the Year Finalists: time to vote Read More »
Every year I give out a number of awards (See 2010 and 2011 awards here). I usually do them all in one post, but this year I’m doing them mostly in separate posts. This is the first post for 2012 awards and this is for Stem Cell Journal of the Year 2012. Some brief background is in order. Last
Stem cell journal of the year 2012: Cell Stem Cell Read More »
Often on this blog I focus on challenges or problems in the stem cell universe, but sometimes it is important to focus on the good news and 2012 had much of that. There are more stem cell-based clinical trials than ever before and there is good reason to believe that many FDA-approved stem cell products
The good news about stem cells for 2012 Read More »
This morning here at The World Stem Cell Summit there was a healthy, frank discussion of the risks associated with receiving unlicensed, unproven stem cell therapies. Dr. Jim Guest presented first and gave a great talk about the risks associated with stem cell treatments. One such risk that was mentioned is inadequate characterization of stem
Frank panel on hidden dangers of stem cell treatments to patients at WSCS2012 Read More »
Last night President Obama decisively won re-election over GOP candidate Mitt Romney. Democrats also won quite a number of Senate seats that only a few months ago seemed destined to go to the GOP. Why was it such a bad night for the GOP? I believe the reasons they lost give insight into a new
Why Romney lost: lessons for needed GOP course correction Read More »
The big scandal about alleged, later mostly recanted transplants of iPS cells (for more on iPS cells see here) into human patients centered on one fellow named Hisashi Moriguchi. For more on the case see here. Clearly Moriguchi is to blame for his lies. The paper Yomiuri is also to blame for splashing the unverified
The odds of Mitt Romney becoming our next President seem to be increasing. If Romney becomes our next president, what will he do about stem cells? He’ll be an active enemy of embryonic stem cell research. He’ll support the crazy personhood movement. Why do I say that? Earlier this year I had a run in
If Romney wins, look for extremist Witherspoon Council to control his stem cell policy Read More »
Why are most brain cancers so difficult to treat leaving the unfortunate patients who suffer from them in dire circumstances so often? The short answer is that we don’t know why. This lack of understanding is like a wall standing between the cures and us for these patients. We have to climb or knockdown this
Brain cancer: why histones including H3.3 are so important Read More »
The Houston Chronicle has posted the response letter from Celltex to the FDA in regard to the FDA Warning Letter issued to Celltex. The Chronicle also has a piece up on the warning letter that is a great read here. My thoughts on the possible paths for Celltex moving forward can be found here. The
Celltex response to FDA says transplants stopped: what are the other key points? Read More »